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In the present study, we report serial measurements of BMC and BW through the first 10 wk of life in 38 VLBW premature infants. We hypothesized that during this period of active growth in weight and length, BW (a measure ofbone diameter and hence of appositional bone growth in infancy and childhood) would increase secondary to increased matrix formation (2) ; however, we predicted BMC would decrease or remain unchanged due to insufficient mineral intake compared to that necessary to achieve the intrauterine rate of bone mineralization (l). Following entry into the study, 15 of 38 infants developed BPD and we hypothesized that as a group they could be distinguished from the 23 infants without BPD because of the high association between BPD and metabolic bone disease (3) . We anticipated that the ratio of BMC to BW would be lower in the BPD group compared to controls.
Population. Thirty-eight VLBW infants (birth weight < 1300 g, gestational age <32 wk) were recruited for this study during the 1st wk of life, after obtaining parental informed consent. Thirty-five infants were white and three infants were black. All infants were appropriate for gestational age. Gestational age was determined from the history of the last menstrual period and corroborated by the Ballard examination for those infants greater than 27 wk gestational age (4) . For those infants less than or equal to 27 wk gestation, fetal ultrasound measurements were used as the second corroborator ofgestational age, when available from the department of obstetrics. If there was more than a 2-wk discrepancy between the two determinations of gestational age, the infant was excluded from the study. All infants were admitted to the neonatal intensive care unit at Madison General Hospital and all were free from major congenital malformations.
Of these 38 infants, 15 were diagnosed subsequently as having BPD. All infants with BPD had the initial diagnosis of the respiratory distress syndrome, required supplemental oxygen for a minimum of 30 days, and had a chest x-ray diagnosis of BPD (hyperexpansion, interstitial densities, focal emphysema) (5). For purposes of comparison, the remaining 23 infants were designated as controls.
Photon absorptiometry. BMC and bone width were measured by a photon absorptiometric system (Lunar Radiation Inc., Madison, WI) in which a collimated 2 mm diameter photon beam from a low activity [ 125 1] "spent source" (20-50 mCi) was passed beneath the one-third distal radius (shaft) of the left forearm. The system has been previously described in detail (1) . Measurements of BMC and bone width were made within the 1st wk of life and subsequently at biweekly intervals. Accuracy, precision, and reproducibility of this system used by us in newborn infants have been published (1) . Immediate reproducibility 925 Abbreviations BMC, bone mineral content BW, bone width BPD, bronchopulmonary dysplasia VLBW, very low birth weight ABSTRACT. We report serial measurements of bone mineral content (BMC), bone width (BW, a measure of appositional bone growth), and the ratio ofBMC:BW by photon absorptiometry of the left radius through the first 10 wk of life in 38 very low birth weight premature infants (birth weight <1300 g, gestational age <32 wk). Fifteen of 38 infants developed bronchopulmonary dysplasia (BPD) and as a group they could not be distinguished from the 23 infants without BPD, despite the high association between BPD and metabolic bone disease. As BPD occurred in the smaller patients, the BPD group had a significantly lower mean birth weight and mean gestational age as compared to controls (950 ± 125 g versus 1119 ± 149, and 28.0 ± 0.8 versus 29.0 ± 1.3 wk). For both control and BPD groups, BMCs did not differ and remained relatively unchanged throughout the first 10 wk of life, lagging significantly behind the intrauterine rate as defined by measuring BMC in 175 infants of varying gestational ages during the first few days of life. BW also did not differ during this period between groups. BW did increase significantly in both groups (from 3.2 ± 0.3 to 3.9 ± 0.4 mm in the controls and from 3.0 ± 0.3 to 3.8 ± 0.4 mm in the BPD group), but remained significantly delayed compared to the intrauterine rate. In both groups, BMC remained relatively constant despite increasing BW and thus BMC/BW decreased during the first 10 wk of life (from 11.5 ± 1.3 to 10.2 ± 1.9 in the controls and from 11.0 ± 1.3 to 8. In a previous publication we demonstrated that photon absorptiometry of the radius can be used with high accuracy, precision, and reproducibility to determine BMC and BW in vivo in fullterm and preterm newborn infants (l). It was found that BMC has a high correlation with gestational age, birth weight, GREER ANO MCCORMICK (without repositioning the arm) for four to six scans performed for each determination of BMC and BW is good with a mean coefficient of variation of 3.9% for BMC and 3.6% for BW (I). The "repositioning error," determined by repeating measurements ofBMC and BW after repositioning the arm in 74 infants is relatively small. The mean percent difference between readings for BMC is 5.5 ± 4.9 (SD) and for BW 5.1 ± 3.5.
Statistical analysis. Data analysis was by Student's t test. Because of the possibility of spurious "significant" findings from multiple statistical analyses, analysis of variance with repeated measures was performed for the longitudinal data to confirm all significant differences. Standard linear regression was also used where appropriate.
Miscellaneous. Weight and intakes of formula or human milk were recorded daily as part of routine hospital care. Length was measured biweekly on a single infant measuring board from Jim's Instruments Manufacturing, Inc., Iowa City, IA.
"Intrauterine"values/or BMC and BW. The rates ofintrauterine bone mineralization and growth in bone width were determined by measuring BMC and BW in 175 Caucasian appropriate for gestational age infants in the first 3 days of life. Infants ranged from 22-42 wk gestation. Results on 114 infants have been previously reported (1) . Of the 61 additional infants reported here, 40 infants were premature «37 wk gestational age).
RESULTS
The results for BMC, BW, and BMC:BW with SDs in 175 infants of varying gestational ages during the first three days of life are shown in Table 1 . Data from Table 1 were used to construct graphs ofintrauterine BMC, BW, and BMC/BW versus postconceptional age used in subsequent figures (1-3). Table 2 contains the clinical data on 38 patients followed longitudinally in this study. As BPD occurred in the smaller patients, the infants in the BPD group had a significantly lower mean birth weight and mean gestational age as compared to controls. In Table 2 , it is also apparent that infants with BPD had longer periods of assisted ventilation, supplemental oxygen therapy, and hospitalization. In addition, 11 of 15 infants with BPD were on chronic furosemide therapy (I mg/kg day parenterally, 2 mg/kg/day orally). The mean duration of furosemide therapy was 109 ± 56 days, eight of 11 infants remaining on furosemide for the duration ofthe study. Nutritionally, all infants received total parenteral nutrition initially and nine infants in each group received 90% or more of their oral calories as human milk. The standard formula utilized was Similac, 20 cal oz. Ten infants in each group received oral calcium and phosphate supplements at some time during the course of the study. Decision for supplementation was at the discretion of the attending physician, the most common reason for supplementation being the low Ca/P intakes in those infants fed human milk. By CajP supplements is meant a high Ca/P containing formula (Similac Special Care, Ross Laboratories, Columbus, OH) or direct supplements ofCa (calcium gluconate) and P (potassium phosphate) added to the feedings, increasing the elemental Ca intake to 150 mg/kg/day and the elemental P intake to 100 mg/kg/day. Dietary intake data for Ca, P, and vitamin D are given in Table 3 .
Only at 38-39 wk did the infants with BPD achieve a significantly higher intake of Ca, P, and vitamin D compared to controls. In general intakes of Ca and P were less than the intrauterine accretion rates. Only the BPD infants achieved an intake of Ca comparable to the intrauterine Ca accretion rate of 150 mg/kg/ day by 38-39 wk gestational age (6) (7) (8) . Presumably the Ca retention rate in these infants was still less than 150 mg/kg/day. Data from the measurements made by photon absorptiometry are depicted in Figues 1 through 3. In Figure 1 , BMC (mg/cm) versus weeks postconception is shown for control and BPD groups. Also shown is the intrauterine curve for bone mineralization, drawn from the data in Table I . Although the BMC for the 23 controls was higher than the 15 infants with BPD throughout the study, at no time did this difference reach statistical significance. However, by 32 wk, both groups were significantly below the intrauterine curve for BMC (p < 0.01), and remained so throughout the study. For both control and BPD groups BMC remained relatively unchanged throughout the first 10 wk of life. Thus BMC did not correlate with postconceptional age in these groups unlike the infants utilized for the intrauterine values (Table I) where there was a very high correlation between BMC and postconceptional age (r = 0.92). We also found no correlation in either BPD or control groups between BMC and Ca/P intakes. There was also no difference in BMC between infants fed formula and human milk. Figure 2 gives the data for bone width (mm) a measure of appositional bone growth. Throughout the study there was no difference in BW between BPD and control groups and both lagged significantly behind the intrauterine curve for BW (also shown in Fig. 2 ) by 34 wk (p < 0.01). However, unlike BMC, BW in both groups significantly increased between 30-31 and 38-39 wk (p < 0.001) and was significantly correlated with postconceptional age (r = 0.82 p < 0.001) as in the infants utilized for the intrauterine values (Table I) . Also, total body length increased significantly (p < 0.00 1) in the control (37.3 ± 1.9 to 44.9 ± 2.2 em) and BPD (36.0 ± 2.6 to 43.8 ± 1.8 em) groups reflecting overall skeletal growtl\ Figure 3 shows the ratio of BMC to BW during the study period. In the intrauterine data (from Table 1 ), BMC/BW linearly increases with gestational age (r = 0.97). In both the control and BPD groups, however, BMC remains relatively constant despite increasing BW. Thus BMC/BW ratio does not increase but decreases in both groups with increasing age, although the decrease is not statistically significant. Weeks Post Conception 
DISCUSSION
These data clearly demonstrate a low bone mineral content despite appositional growth of cortical bone (as measured by radial bone width) in VLBW infants compared to the intrauterine values for BMC during the first 10 wk oflife (Fig. I) . Although appositional bone growth occurred, it was still considerably less than the intrauterine rate (Fig. 2) . Overall skeletal growth is documented by increases in length during the study period. The fact that BMC and appositional bone growth (BW) is decreased in these infants during a time when skeletal growth is occurring, suggests a disorder of formation and/or remodeling of cortical bone. This is supported by many reports of diffusely demineralized bones in routine x-rays of some growing premature infants with metabolic bone disease (9) (10) (11) (12) . This disorder may be secondary to a defect in the overall mineralization process ofcortical bone or perhaps due to extensive cortical thinning and remodeling of normally mineralized bone, or a combination thereof.
One previous group has reported delay in BMC in growing premature infants using photon absorptiometry (13, 14) . In the first of their reports only three infants less than 32 wk gestation were studied and no measurements of bone width were made. Overall skeletal growth was not reported. In six infants, 31-32 ... Weeks Post Conception 
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GREER AND MCCORMICK wk gestation, no increase in BMC was noted from birth to 10 wk. In the second of these reports which included infants from the first, an increase in BMC in infants 28-32 wk gestation on both a standard and experimental formula (high Ca, high P) was reported during the first 10 wk oflife (14) . No measurements of BW were made. It is hard to reconcile our own data with these somewhat conflicting reports, but it is apparent that our population was smaller and of a lower mean gestational age.
In this study, intakes of Ca and P were generally less than those necessary to support the intrauterine rate of bone mineralization (6) (7) (8) . The insufficient intakes of Ca and P would explain the lack of correlation between BMC and Ca and P intakes and would also explain the lack of catch up bone mineralization in either group (Fig. 1) . We could not rule out that catch-up bone mineralization might have occurred with higher Ca/P intakes as has been reported in other studies (14, IS) .
It is possible that the low bone mineral content is in part due to a vitamin D deficiency rather than solely an inadequate intake of Ca and P. We did not measure serum vitamin D levels in these infants, although others have reported serum levels of 1,25 (OHh vitamin D (the most active metabolite of vitamin D) to be high in premature infants on similar intakes of vitamin D (16) . All infants in this study received the recommended vitamin D intake for premature infants of 400 IU/day once full oral feeds were achieved and this was continued throughout the study (17, 18) .
We were surprised that bone mineral content was delayed to an equal degree in both control and BPD groups. This is despite available evidence which suggests that VLBW infants with BPD are at risk for metabolic bone disease (2) . Such infants generally have a more complicated hospital course, require chronic fluid restriction (further restricting Ca and P intakes), and receive regular furosemide therapy as part of their treatment. Our infants with BPD were "sicker" than the control infants as judged by duration of assisted ventilation, hospitalization, and supplemental oxygen therapy. Eleven of IS infants with BPD were also on chronic furosemide therapy, which is known to increase urinary calcium losses in premature infants (19, 20) . Our data would suggest factors other than the presence or absence of BPD are responsible for the low bone mineral content in very premature infants. Extreme prematurity and inadequate intakes of Ca and P in these infants with or without BPD seem to be very important. Although the BMC was generally less in BPD than controls, the difference was not significant. Our two groups were not controlled for birth weight and gestational age which would probably account for much of this observed difference in BMC as our infants with BPD were of significantly smaller birth weight and gestational age ( Table 1) . As documented previously, BMC correlates with birth weight and gestational age (1) .
Other investigators have reported bone hypomineralization in growing premature infants by photon absorptiometry as well as by other less sensitive techniques. However, in this study we have clearly documented a decrease in BMC despite appositional and overall skeletal growth, indicating a disorder of formation and/ or remodeling of growing cortical bone. The fact that this occurred to an equal degree in growing VLBW premature infants with and without bronchopulmonary dysplasia was unexpected.
